Our objective was to estimate the strength of the effect of the I148M (rs738409 C/G) patatin‐
like phospholipase domain containing 3 (PNPLA3) variant on nonalcoholic fatty liver …

Nonalcoholic fatty liver disease (NAFLD) is a significant health burden in adolescents and
young adults (AYAs) which has substantially risen in prevalence over the last decades. The …

Liver fat deposition related to systemic insulin resistance defines non-alcoholic fatty liver
disease (NAFLD) which, when associated with oxidative hepatocellular damage …

Approximately 130 attendees convened on February 19–22, 2012 for the first ISMRM‐
sponsored workshop on water–fat imaging. The motivation to host this meeting was driven …

Objective: This meta-analysis is to investigate the relationship between the patatin-like
phospholipase domain containing 3 (PNPLA3) rs738409 polymorphism and the …

Non-alcoholic fatty liver disease (NAFLD) is a multi-faceted disorder, which ranges from
simple steatosis to non-alcoholic steatohepatitis (NASH) with/without fibrosis. The effects of …

We conducted a meta-analysis to assess the association between patatin-like
phospholipase domain-containing 3 (PNPLA3) rs738409 polymorphism and nonalcoholic …

The liver plays a unique, central role in regulating lipid metabolism. In addition to influencing
hepatic function and disease, changes in specific pathways of fatty acid (FA) metabolism …

Background: Recently, a genetic variant (rs738409; C→ G) of the PNPLA3 gene was
identified to be associated with increased hepatic fat deposition, and the effect was more …

Currently, Non-Alcoholic Fatty Liver Disease (NAFLD) is the most prevalent form of chronic
liver disease in children and adolescents worldwide. Simultaneously to the epidemic …